UAB has enrolled the first U.S. patient in a Phase III clinical trial for a drug that, if successful, would be a significant clinical breakthrough for reducing pre-term births and infant mortality.

Gregory Friedman, M.D., is working to combat medulloblastoma — the most common malignant pediatric brain tumor — using genetically altered viruses that kill cancer cells and leave normal cells untouched. 

The first HPV and cytology study conducted in rural Nepal suggests self-collected samples may offer effective screening for the deadly infection.

Eating more fruits and vegetables is good for a number of reasons, but weight-loss isn’t necessarily one of them, UAB researchers say.

Professor David Schwebel, Ph.D., developed a new virtual-reality system to help reduce pedestrian injuries and deaths among children.

Research that sheds light on the way gliomas migrate and cause brain tumors may reveal a new avenue to kill them. The findings, published June 19 in Nature Communications, show that gliomas disrupt normal neural connections and hijack control of blood vessels — which may open the door for chemotherapy.

A new initiative in the School of Medicine will deliver the data to help drive research and advance discoveries.

Medical advances and interventions may have helped reduce the effects of obesity on lifespan, especially for women, says findings published in Obesity Reviews.

The partnership combines genomics expertise with leadership in research and clinical medicine to speed efforts to deliver personalized therapies and cures.

New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.